Literature DB >> 20657435

An effective microwave-induced iodine-catalyzed method for the synthesis of quinoxalines via condensation of 1,2-diamines with 1,2-dicarbonyl compounds.

Debasish Bandyopadhyay1, Sanghamitra Mukherjee, Robert R Rodriguez, Bimal K Banik.   

Abstract

A microwave-induced iodine-catalyzed simple, rapid and convenient synthesis of different types of quinoxalines via condensation of 1,2-diamines with 1,2-dicarbonyl compounds has been accomplished with an excellent yield.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657435      PMCID: PMC6264210          DOI: 10.3390/molecules15064207

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

A quinoxaline moiety serves as the nucleus for the synthesis of several biologically active compounds including antitumor [1], antimycobacterial [2] and antidepressant [3] drugs. Some antibiotics, such as levomycin, actinoleutin and echinomycin also contain a quinoxaline scaffold and these are known to inhibit the growth of Gram positive bacteria [4] and are active against various transplantable tumors [5]. As a part of our ongoing research leading to the synthesis of novel anticancer drugs [6,7,8,9,10,11] we became interested in the development of a new, efficient and practical method to synthesize quinoxalines. Although diverse methods for the synthesis of substituted quinoxalines are described in the literature [12,13], the most common method for their preparation is a condensation reaction between a 1,2-diamine and 1,2 dicarbonyl compound. Clearly, all while these methods have extended the scope for the synthesis of this type of heterocycles, they have limitations in some of the following areas: low yield, long reaction time, difficult product isolation procedure and use of toxic metal catalysts as well as hazardous solvents. In this paper, we describe an automated microwave-assisted extremely rapid iodine-catalyzed method for the synthesis of substituted quinoxalines in high yields in aqueous ethanol via the diamine-dicarbonyl compound condensation route (Scheme 1).
Scheme 1

Microwave-induced iodine-catalyzed synthesis of quinoxalines.

Microwave-induced iodine-catalyzed synthesis of quinoxalines.

2. Results and Discussion

Our group has reported the synthesis and biological evaluation of various β-lactams as novel anticancer agents [6,7,8,9,10,11]. The synthesis of β-lactams through imines requires a dicarbonyl compound and an amine. We have been conducting research on imines for the last 20 years. Our study suggests that condensation of 1,2-diamino compounds and 1,2 dicarbonyl compounds in the presence of a mild acidic reagent will lead to the synthesis of quinaxolines (Scheme 1). This hypothesis has been tested by reacting several diamines with various dicarbonyl compounds in the presence of iodine (catalytic amount, 5 mol %) in ethanol/water (1:1) using a microwave-induced method. The model reaction between o-phenylenediamine and phenylglyoxal monohydrate in the presence of iodine as catalyst using microwave irradiation has been performed in different solvent systems (Table 1). However, best results were obtained when EtOH/H2O (1:1) was used as solvent.
Table 1

Reaction between o-phenylene diamine and phenylglyoxal monohydrate in the presence of iodine (5 mol%) in different solvents under microwave irradiation.

EntrySolventTime (min.)Yield (%)
1Methanol341
2Ethanol365
3Tetrahydrofuran548
4Dichloromethane327
5THF/Water (1:1)536
6Water538
7Acetonitrile372
8Ethanol/Water (1:1)30 sec.99
Reaction between o-phenylene diamine and phenylglyoxal monohydrate in the presence of iodine (5 mol%) in different solvents under microwave irradiation. Next the reaction conditions were tested with a variety of 1,2-diamines and 1,2-dicarbonyl compounds. In all cases the reaction was completed within 2–3 minutes at 50 °C in a CEM microwave and the corresponding quinoxalines were isolated in excellent yields (Table 2).
Table 2

Synthesis of quinoxalines via condensation of 1,2-diamines with 1,2-dicarbonyl compounds with iodine as the catalyst in water/ethanol (1:1) under microwave induces reaction (Scheme 1).

EntryAmineDicarbonyl CompoundsMWI (Power/temp/time)ProductYield (%)a
1300 watts50°C30 sec 99
2300 watts50 °C30 sec 90
3300 watts50 °C30 sec 92
4300 watts50 °C45 sec 95
5300 watts50 °C1 min 98
6300 watts50 °C1 min 86
7300 watts50 °C1.5 min 90
8300 watts50 °C30 sec 85
9300 watts50 °C2.5 min 95
10300 watts50 °C2 min 87
11300 watts50 °C2 min 15 sec 92
12300 watts50 °C45 sec 93
13300 watts50 °C5 minwithout catalyst No reaction

a isolated yield.

Synthesis of quinoxalines via condensation of 1,2-diamines with 1,2-dicarbonyl compounds with iodine as the catalyst in water/ethanol (1:1) under microwave induces reaction (Scheme 1). a isolated yield. The reaction proceeded equally well irrespective of the nature of substituents (chloro, nitro and methoxy groups) present in the amino component. The reaction between 1,2-diamines and 1,2 dicarbonyl compounds does not proceed at all without iodine (Entry 13).

3. Experimental Section

3.1. General

Melting points were determined in a Fisher Scientific electrochemical Mel-Temp* manual melting point apparatus (Model 1001) equipped with a 300°C thermometer. Elemental analyses (C, H, N) were conducted using the Perkin-Elmer 2400 series II elemental analyzer, their results were found to be in good agreement (± 0.2%) with the calculated values for C, H, N. FT-IR spectra were registered on a Bruker IFS 55 Equinox FTIR spectrophotometer as KBr discs. 1H-NMR (300 MHz) and 13C-NMR (75.4 MHz) spectra were obtained at room temperature with JEOL Eclipse-300 equipment using TMS as internal standard and CDCl3 as solvent. Analytical grade chemicals (Sigma-Aldrich incorporation) were used throughout the project. Deionized water was used for the preparation of all aqueous solutions.

3.2. General procedure for the synthesis of quinoxalines

The diamine (1 mmol) and the dicarbonyl compound (1 mmol) were dissolved in ethanol/water (1:1, 1 mL). A catalytic amount (5 mol%) of iodine was added and the mixture was irradiated using a CEM microwave (50 °C and power level 300 µ) as described in Table 2. The reaction was monitored by TLC. After the completion of the reaction, dichloromethane (10 mL) was added to the reaction mixture and it was then washed successively with 5% sodium thiosulphate solution (2 mL) and brine (2 mL). The organic layer was dried with anhydrous sodium sulfate and concentrated. Quinoxalines were found to be. No column chromatography was needed for the purification of the products and pure products (~95% by proton NMR) were isolated through crystallization (dichloromethane-hexane). Compounds obtained from entries 5, 6 and 9–11 (Table 2) were previously reported [13,14,15]. The remaining compounds (entries 1–4, 7, 8 and 12, Table 2) have been characterized by IR, NMR and mass spectral data. Our products gave satisfactory spectral and mp data matching with the reported values. We also carried out a reaction of benzil and ortho-phenylenediamine in absence of iodine (entry 13) following the published procedure [14]. However, no reaction took place at 50 °C without catalyst, even after 5 minutes of microwave irradiation; thus suggesting a lowering of the activation energy in the presence of the catalyst that also reduces the possibility of product loss due to partial charring.

4. Conclusions

In conclusion, the iodine-catalyzed microwave-induced quinoxaline synthesis as described herein is very simple, environmentally friendly and extremely rapid and affords high (almost quantitative) yields. Our method is versatile since aliphatic and aromatic amino compounds can be used in this reaction and these substrates all produce quinoxalines with remarkable success.
  11 in total

1.  Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

Authors:  S T Hazeldine; L Polin; J Kushner; J Paluch; K White; M Edelstein; E Palomino; T H Corbett; J P Horwitz
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

2.  Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of some chrysene derivatives.

Authors:  F F Becker; B K Banik
Journal:  Bioorg Med Chem Lett       Date:  1998-10-20       Impact factor: 2.823

3.  Recognition elements that determine affinity and sequence-specific binding to DNA of 2QN, a biosynthetic bis-quinoline analogue of echinomycin.

Authors:  C Bailly; S Echepare; F Gago; M J Waring
Journal:  Anticancer Drug Des       Date:  1999-06

4.  The mode of action of quinoxaline antibiotics. Interaction of quinomycin A with deoxyribonucleic acid.

Authors:  K Sato; O Shiratori; K Katagiri
Journal:  J Antibiot (Tokyo)       Date:  1967-09       Impact factor: 2.649

5.  Polycyclic aromatic compounds as anticancer agents: structure-activity relationships of chrysene and pyrene derivatives.

Authors:  B K Banik; F F Becker
Journal:  Bioorg Med Chem       Date:  2001-03       Impact factor: 3.641

6.  Polycyclic aromatic compounds as anticancer agents: synthesis and biological evaluation of dibenzofluorene derivatives.

Authors:  F F Becker; C Mukhopadhyay; L Hackfeld; I Banik; B K Banik
Journal:  Bioorg Med Chem       Date:  2000-12       Impact factor: 3.641

Review 7.  Synthesis, electrophilic substitution and structure-activity relationship studies of polycyclic aromatic compounds towards the development of anticancer agents.

Authors:  B K Banik; F F Becker
Journal:  Curr Med Chem       Date:  2001-10       Impact factor: 4.530

Review 8.  Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures.

Authors:  Ahmed Kamal; K Laxma Reddy; V Devaiah; N Shankaraiah; M V Rao
Journal:  Mini Rev Med Chem       Date:  2006-01       Impact factor: 3.862

9.  Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.

Authors:  Lainne E Seitz; William J Suling; Robert C Reynolds
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

10.  Stereoselective synthesis of beta-lactams with polyaromatic imines: entry to new and novel anticancer agents.

Authors:  Indrani Banik; Frederick F Becker; Bimal K Banik
Journal:  J Med Chem       Date:  2003-01-02       Impact factor: 7.446

View more
  7 in total

1.  An expeditious green route toward 2-aryl-4-phenyl-1H-imidazoles.

Authors:  Debasish Bandyopadhyay; Lauren C Smith; Daniel R Garcia; Ram N Yadav; Bimal K Banik
Journal:  Org Med Chem Lett       Date:  2014-09-20

2.  Green Hydrothermal Synthesis of Fluorescent 2,3-Diarylquinoxalines and Large-Scale Computational Comparison to Existing Alternatives.

Authors:  Fabián Amaya-García; Michael Caldera; Anna Koren; Stefan Kubicek; Jörg Menche; Miriam M Unterlass
Journal:  ChemSusChem       Date:  2021-03-26       Impact factor: 8.928

3.  Bismuth nitrate-induced microwave-assisted expeditious synthesis of vanillin from curcumin.

Authors:  Debasish Bandyopadhyay; Bimal K Banik
Journal:  Org Med Chem Lett       Date:  2012-04-20

4.  A microwave-assisted bismuth nitrate-catalyzed unique route toward 1,4-dihydropyridines.

Authors:  Debasish Bandyopadhyay; Stephanie Maldonado; Bimal K Banik
Journal:  Molecules       Date:  2012-03-05       Impact factor: 4.411

5.  An expeditious iodine-catalyzed synthesis of 3-pyrrole-substituted 2-azetidinones.

Authors:  Debasish Bandyopadhyay; Jessica Cruz; Ram N Yadav; Bimal K Banik Banik
Journal:  Molecules       Date:  2012-09-28       Impact factor: 4.411

6.  Fe/Co-MOF Nanocatalysts: Greener Chemistry Approach for the Removal of Toxic Metals and Catalytic Applications.

Authors:  Fares T Alshorifi; Shady M El Dafrawy; Awad I Ahmed
Journal:  ACS Omega       Date:  2022-06-27

7.  A High-Throughput Screening Method for Determining the Optimized Synthesis Conditions of Quinoxaline Derivatives Using Microdroplet Reaction.

Authors:  Yanmei Yang; Junmin Liu; Zhenzhen Chen; Weihua Niu; Ran Li; Le Niu; Peng Yang; Xiaoyan Mu; Bo Tang
Journal:  Front Chem       Date:  2020-09-10       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.